Skip to main content
. 2016 Sep 13;65(11):1895–1905. doi: 10.1136/gutjnl-2015-311292

Figure 2.

Figure 2

Potential clinical applications of epigenetic mechanisms. Dysregulated epigenetic mechanisms are characteristic of both (1) liver cancer and (2) liver fibrosis and are readily examined from biopsy tissue. (A) Cell-free DNA, extracellular microRNAs and nucleosomes from necrotic/apoptotic cells can normally be detected in the circulation, of which the liver provides a proportion; aberrant epigenetic signatures associated with (B) cancer and (C) fibrosis are released into the circulation, potentially providing blood-based markers that could be used to aid diagnosis, prognosis and theranostics.